One connector, four scholarly indexes, real DOIs and legal free PDFs. Works in Claude and ChatGPT.
Paste it into Claude or ChatGPT as a custom connector. 3-day free trial.
Elizabeth Demers, Jurian Hendrikse, Philip P. M. Joos, Baruch Itamar Lev
Environmental, social and governance ("ESG") scores have been widely touted as indicators of share price resilience during the COVID-19 crisis. Contrary to this conventional wisdom, we present robust evidence that once industry affiliation, market-based measures of risk and accounting-based measures of performance, financial position and intangibles investments have been controlled for, ESG offers no such positive explanatory power for returns during the COVID crisis. Specifically, ESG is insignificant in fully specified returns regressions for each of the Q1 2020 COVID market crisis period and for the full COVID year of 2020. By contrast, a measure of the firm's stock of investments in internally generated intangible assets is an economically and statistically significant positive determinant of returns during each of the Q1 market implosion and full 2020 COVID year periods. Our results are robust to alternative measures of returns, as well as for using Refinitiv, Refinitiv II and MSCI data to capture ESG performance. We conclude that ESG did not immunize stocks during the COVID-19 crisis, but those investments in intangible assets did.
Formatted from the source metadata, not typed by hand. For a whole reference list, use the citation generator or ask your assistant through Find Research.
Demers, E., Hendrikse, J., Joos, P. P. M., & Lev, B. I. (2021). ESG did not immunize stocks during the COVID‐19 crisis, but investments in intangible assets did. Journal of Business Finance & Accounting, 48(3-4), 433–462. https://doi.org/10.1111/jbfa.12523
Demers, Elizabeth, et al. "ESG did not immunize stocks during the COVID‐19 crisis, but investments in intangible assets did." Journal of Business Finance & Accounting, vol. 48, no. 3-4, 2021, pp. 433–462, https://doi.org/10.1111/jbfa.12523.
Demers, Elizabeth, Jurian Hendrikse, Philip P. M. Joos, and Baruch Itamar Lev. "ESG did not immunize stocks during the COVID‐19 crisis, but investments in intangible assets did." Journal of Business Finance & Accounting 48, no. 3-4 (2021): 433–462. https://doi.org/10.1111/jbfa.12523.
Demers E., Hendrikse J., Joos P. P. M. [и др.] ESG did not immunize stocks during the COVID‐19 crisis, but investments in intangible assets did // Journal of Business Finance & Accounting. — 2021. — Vol. 48, № 3-4. — P. 433–462. — URL: https://doi.org/10.1111/jbfa.12523
@article{demers2021immunize,
title = {{ESG did not immunize stocks during the COVID‐19 crisis, but investments in intangible assets did}},
author = {Elizabeth Demers and Jurian Hendrikse and Philip P. M. Joos and Baruch Itamar Lev},
journal = {Journal of Business Finance \& Accounting},
year = {2021},
volume = {48},
number = {3-4},
pages = {433--462},
doi = {10.1111/jbfa.12523},
url = {https://doi.org/10.1111/jbfa.12523}
}TY - JOUR AU - Demers, Elizabeth AU - Hendrikse, Jurian AU - Joos, Philip P. M. AU - Lev, Baruch Itamar TI - ESG did not immunize stocks during the COVID‐19 crisis, but investments in intangible assets did JO - Journal of Business Finance & Accounting VL - 48 IS - 3-4 SP - 433 EP - 462 PY - 2021 DA - 2021/03/01 DO - 10.1111/jbfa.12523 UR - https://doi.org/10.1111/jbfa.12523 ER -
Add Find Research to Claude or ChatGPT and ask in plain language. The assistant reads this record, finds the papers around it and cites only what it actually found:
Setup takes about a minute: add the connector, then start the free trial.
Record from OpenAlex; open-access location from Unpaywall and the indexes. Find Research links only to legal copies.